Introduction
Mycoplasma is the smallest and simplest self limiting bacteria. It is the commonest cause of primary atypical pneumonia resistant to ?-lactam antibiotics in older children and young adults. Clinical diagnosis of Mycoplasma pneumoniae pneumonia is difficult as viral and other pneumonias show similar clinical features. Numerous studies were undertaken that provided new insights into the various clinical presentations associated with M. pneumoniae infection. 1,2 Few reports showed that it could also cause severe disease not limited to the respiratory tract but involving extra-pulmonary manifestations. 3 The most common clinical findings of these patients were cough and fever where most of them had benign course and survived. The white blood cell count was often normal. However, extensive pneu-monia can produce a profound leukocytosis. 1 In a clinical setting where M. pneumoniae infection is suspected, serology is often used in diagnosis. Previous studies compared the clinical features of patients with M. pneumoniae pneumonia to other pathogens and these studies were predominantly adult case series rather than involving children. 2 A study done in Singapore and Finland showed that the majority of M. pneumoniae infections were in school-aged children. 4 The increasing seroprevalence rates of M. pneumoniae after 2 years of age should alert clinicians to consider the organism in the differential diagnosis of infectious diseases in this age group. 5 Hence, the above prompted us to conduct a study on clinical features, laboratory investigation and antimicrobial therapy of children infected with M. pneumoniae in the paediatric ward of our tertiary hospital, Universiti Kebangsaan Malaysia Medical Centre. 10 9 /L), were in the normal range.When comparing between the two groups, there were no significant difference in the full blood count parameters.
Materials & methods

Clinical response after antimicrobial therapy:
During admission, antibiotics were prescribed for 100 (90.1%) children. The patients were treated with a wide range of antimicrobial regimens where they were generally classified into ß-lactams monotherapy, macrolides monotherapy and the combination of a ß-lactam plus macrolide.
Sixty four patients received ß-lactam monotherapy and 49 (76.6%) of them were cured ( Table -111 ). On the other hand, only 18 patients received macrolide monotherapy which cured 100% patients. Although there was significant difference between three groups of regimen in term of efficacy ( p <0.023).
Discussion:
M. pneumoniae has been found to be an important infectious agent for the children's pneumonia. In the present study 40.5% children had serological evidence of M. pneumoniae infection. Previous studies suggested that M. pneumoniae causes infection 20 -35 % of children in Thailand, 6 Singapore. 7 This variation might be due difference of study design and country.
Relating to clinical manifestation majority of our patients presented with fever and cough. These are consistent with the previous studies which showed that fever and cough were the commonest presentation among patients with M. pneumoniae infection. 8 On the contrary to previous studies; this showed that absence of cough would be more suggestive of M.
pneumoniae infection. Other studies 8 only included patients that were suspected of having either pneumonia, upper respiratory tract infection or both. From the analysis, there was no association between duration of fever longer than six days and the serology result. However, previous study reported that the duration of fever in children with M. pneumoniae infection were likely to be longer as compared to those without infection. 9 This is probably due to the fact that 53.3% of our seropositive children are less than five years old.
The clinical signs studied in this research including tachypnoea, bronchial breathing and crackles were not found to have a significant association with serology results. Although another author 9 demonstrated that crackles were more likely in M. pneumoniae infection; there were no other studies that supported this.
Study by Chen et al. 10 showed significant association between M. pneumoniae infection with neutropaenia and thrombocytopaenia where it was thought due to formation of antiplatelet and antineutrophil autoantibodies that caused the cytopaenias. On the other hand, an Australian study showed that patients with M. pneumoniae were more likely to develop thrombocytosis. 
